Cancer Immunology and Immunotherapy by Glenn DranoffCancer Immunology and Immunotherapy by Glenn Dranoff

Cancer Immunology and Immunotherapy

byGlenn Dranoff

Paperback | May 29, 2013

Pricing and Purchase Info

$267.07 online 
$317.50 list price save 15%
Earn 1,335 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.
Title:Cancer Immunology and ImmunotherapyFormat:PaperbackDimensions:306 pages, 23.5 × 15.5 × 0.1 inPublished:May 29, 2013Publisher:Springer-Verlag/Sci-Tech/TradeLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3642267882

ISBN - 13:9783642267888

Look for similar items by category:


Table of Contents

Immune infiltration in human cancer: prognostic significance and disease control.- Subversion and coercion - The art of redirecting tumor immune surveillance.- STAT3: A target to enhance antitumor immune response.- Biology and clinical observations of regulatory T cells in cancer immunology.- Dendritic cell subsets as vectors and targets for improved cancer therapy.- Identification of human idiotype-specific T cells in lymphoma and myeloma.- Modulation of CTLA-4 and GITR for cancer immunotherapy.- Immunologically active biomaterials for cancer therapy.- Subject index

Editorial Reviews

From the reviews:"This book comprises 13 reviews, contributed by members of a cross-section of groups working in the . field of cancer immunology. . this book is at its best when considering small and apparently discrete topics ­­- its strength comes from being able to read all of these ideas on one place. . Overall, this book gives a thorough and detailed overview of the current state of basic and translational research into cancer immunology . . It's probably most appropriate for researchers . ."­­­ (Victoria Lawson, Immunology News, November, 2011)